We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALKS market cap is 4.53B. The company's latest EPS is USD 2.1293 and P/E is 12.70.
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 276.22M | 252.36M | 304.67M | 287.6M | 617.4M |
Operating Income | -34.46M | -252.14M | -20.58M | -47.49M | 239.19M |
Net Income | -30.14M | -63.97M | -28.25M | -41.85M | 237.07M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.17B | 1.04B | 1.17B | 1.11B | 1.66B |
Operating Income | -175.48M | -112.43M | -29.29M | -142.27M | 414.12M |
Net Income | -196.62M | -110.86M | -48.17M | -158.27M | 355.76M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.96B | 1.94B | 1.96B | 1.92B | 2.19B |
Total Liabilities | 875.09M | 899.05M | 920.23M | 917.15M | 906.75M |
Total Equity | 1.08B | 1.04B | 1.04B | 1.01B | 1.28B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.81B | 1.95B | 2.02B | 1.96B | 2.14B |
Total Liabilities | 719.96M | 882.75M | 911.9M | 920.23M | 933.54M |
Total Equity | 1.09B | 1.07B | 1.11B | 1.04B | 1.2B |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 19.37M | 20M | 21.04M | -21.3M | 194.41M |
Investing | -101.18M | -92.28M | -64.54M | 72.85M | 193.7M |
Financing | -1.09M | -1.3M | -1.57M | -22.62M | -14.78M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 72.08M | 82.84M | 101.72M | 21.04M | 401.35M |
Investing | -141.83M | -11.48M | -66.2M | -64.54M | 53.36M |
Financing | 6.77M | -2.17M | 29.07M | -1.57M | -289.71M |
Market Cap | 4.53B |
Price to Earnings Ratio | 12.70 |
Price to Sales Ratio | 2.72 |
Price to Cash Ratio | 9.88 |
Price to Book Ratio | 3.76 |
Dividend Yield | - |
Shares Outstanding | 167.08M |
Average Volume (1 week) | 1.53M |
Average Volume (1 Month) | 2.11M |
52 Week Change | 0.41% |
52 Week High | 33.71 |
52 Week Low | 22.01 |
Spread (Intraday) | 1.14 (4.08%) |
Company Name | Alkermes PLC |
Address |
connaught house dublin D04 C5Y6 |
Website | https://www.alkermes.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions